Freelance/Contract - Pharmacovigilance (GVP) Auditor - Spanish/English - Remote based

Freelance/Contract - Pharmacovigilance (GVP) Auditor - Spanish/English - Remote based

Posted Today by ProPharma

Negotiable
Undetermined
Remote
United Kingdom

Summary: The role of Pharmacovigilance (GVP) Auditor at ProPharma involves conducting a critical GVP audit focused on Patient Support Programmes for a key client in Q2 2026. The position requires fluency in both Spanish and English and is intended for independent consultants or those within small consultancies based in the UK/EU. The audit will be performed remotely and requires extensive experience in pharmacovigilance auditing. Candidates must possess a relevant educational background and strong stakeholder management skills.

Key Responsibilities:

  • Conduct a GVP audit focusing on Patient Support Programmes for a key client.
  • Perform the audit remotely for one full day, with additional hours for preparation and write-up.
  • Manage stakeholder relationships effectively throughout the audit process.
  • Ensure compliance with pharmacovigilance standards and practices.

Key Skills:

  • BSc or higher in life-sciences or medical discipline.
  • Extensive experience in Pharmacovigilance (GVP) auditing.
  • Demonstrated experience with patient support programmes from an auditor perspective.
  • Fluency in English and Spanish (verbal & written).
  • Excellent stakeholder management skills.

Salary (Rate): undetermined

City: undetermined

Country: United Kingdom

Working Arrangements: remote

IR35 Status: undetermined

Seniority Level: undetermined

Industry: Other

Detailed Description From Employer:

Company Description For the past 20 years, ProPharma has improved the health and wellness of patients by providing advice and expertise that empowers biotech, med device, and pharmaceutical organizations of all sizes to confidently advance scientific breakthroughs and introduce new therapies. As the world’s largest RCO (Research Consulting Organization), ProPharma partners with its clients through an advise-build-operate model across the complete product lifecycle. With deep domain expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma offers an end-to-end suite of fully customizable consulting solutions that de-risk and accelerate our partners’ most high-profile drug and device programs.

Job Description We are currently looking to partner with Pharmacovigilance (GVP) Auditor who can partner with us to perform a critical GVP audit for one of our key clients in Quarter 2 2026 (dates are flexible within the period). This audit specifically focuses on Patient Support Programmes and it requires 1 full day auditing on a remote basis (additional hours put aside for preparation & write up). The audit also requires fluency in Spanish and English; you must be currently based in the UK/EU and ideally working as an independent Consultant or within a small consultancy.

Qualifications required Must have an education of at least BSc or higher within a life-sciences or medical discipline Extensive experience in Pharmacovigilance (GVP) auditing is required with the life-sciences sector Demonstrated experience working on patient support programmes (from an auditor perspective) is highly preferred Thorough experience working as a GVP Auditor is a must Fluent in English and Spanish (verbal & written) Can perform the audit within Q2 of 2026 Excellent stakeholder management skills

Additional information We celebrate our differences and strive to create a workplace where each person can be their authentic self. We are committed to diversity, equity, and inclusion. Employees are encouraged to unleash their innovative, collaborative, and entrepreneurial spirits. With a holistic approach as an Equal Opportunity Employer, we provide a safe space where all employees feel empowered to succeed.

***ProPharma Group does not accept unsolicited resumes from recruiters/third parties. Please, no phone calls or emails to anyone regarding this posting.***